HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Related

473.358

+1.9750.42%

Number of Gainers:30

Number of Losers:18

Number of Flat:7

PE:- -

High:480.368

Open:471.419

Low:469.310

Close:471.383

Loading ...

Hansoh Pharmaceutical Group Announces Breakthrough-Therapy Designation for B7-H4-Targeted ADC HS-20089 in China

BRIEF-Hansoh Pharmaceutical Says NMPA Granted Breakthrough-Therapy-Designated Drug For HS-20089

Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated Drug for B7-H4-Targeted Antibody-Drug Conjugate Hs-20089

THOMSON REUTERS

Innovent Biologics - Qtrly Achieved Total Product Revenue Exceeding RMB2.4 Bln

THOMSON REUTERS

Central China New Life Makes Senior Management Changes

MT Newswires Live

BRIEF-Central China New Life Says Dai Jiling Resigns As Executive Director And CEO

Central China New Life - Guo Liyuan Appointed by Board as Executive Director and CFO

THOMSON REUTERS

BRIEF-Sunac Services Exits Zhangtai Services Group

BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation

Beigene Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.

THOMSON REUTERS

Innovent Announces First Patient Dosed in Phase 1 Study of Ibi3020, Global First-in-Class Dual Payload Ceacam5 ADC, in Patients With Advanced Malignancies

THOMSON REUTERS

Sunac Services Holdings Ltd. Publishes 2024 Annual Report

Sunac Services Holdings Ltd - Exits Zhangtai Services Group

THOMSON REUTERS

China Suntien Green Energy's Q1 Profit Swells 15%

MT Newswires Live

Microport Scientific - Qtrly Net Profit for Shanghai Microport Endovascular Medtech RMB129.6 Mln

THOMSON REUTERS

JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Decreases to 6.28% on April 24 From 7.33% - HKEX

THOMSON REUTERS

Tong Ren Tang Technologies' Q1 Profit Reaches 227 Million Yuajn

MT Newswires Live

BUZZ-China's WuXi AppTec jumps as Q1 profit soars

Innovent Biologics Inc. Releases Environmental, Social and Governance Report

China Resources Mixc Lifestyle Services Ltd. Publishes 2024 Annual Report

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1583/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":473.35806,"timestamp":1746000495834,"preClose":471.3829,"halted":0,"volume":449463537,"delay":0,"changeRate":0.00419,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed Labour Day","change":1.975159,"latestTime":"04-30 16:00:00","open":471.41876,"high":480.36774,"low":469.31015,"amount":12553014206,"amplitude":0.023458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":2.238051,"peRate":21.705564,"turnoverRate":0.003086,"increases":30,"decrements":22,"flats":2,"marketCap":2669831540224,"floatMarketCap":2093905376768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":480.36774,"amplitude":0.023458,"preClose":471.3829,"low":469.31015,"pbRate":"2.238051","latestPrice":473.35806,"volume":449463537,"delay":0,"open":471.41876,"prevYearClose":446.93042,"prevWeekClose":466.075,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":474.384,"twentyDayClose":512.397,"sixtyDayClose":448.401,"secType":"PLATE","market":"HK","turnoverRate":0.003086,"peRate":21.705564,"marketCap":2669831540224,"floatMarketCap":2093905376768,"timestamp":1746000495834,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":30,"down":18,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532027318","title":"Hansoh Pharmaceutical Group Announces Breakthrough-Therapy Designation for B7-H4-Targeted ADC HS-20089 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2532027318","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532027318?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:22","pubTimestamp":1746094961,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. has announced that their self-developed B7-H4-targeted antibody-drug conjugate, HS-20089, has been granted Breakthrough-Therapy-Designated Drug status by the National Medical Products Administration  of China. This designation is for the proposed treatment of platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer patients. HS-20089, which utilizes a topoisomerase inhibitor payload, is currently undergoing multiple clinical trials in China, with the highest research stage being Phase III. The approval marks a significant step forward in the development of this promising therapy for gynecological tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL1spMG5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"gpt_icon":0},{"id":"2532022020","title":"BRIEF-Hansoh Pharmaceutical Says NMPA Granted Breakthrough-Therapy-Designated Drug For HS-20089","url":"https://stock-news.laohu8.com/highlight/detail?id=2532022020","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532022020?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:21","pubTimestamp":1746094896,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Says NMPA Granted Breakthrough-Therapy-Designated Drug For HS-20089May 1  - Hansoh Pharmaceutical Group Company Ltd 3692.HK:NMPA GRANTED BREAKTHROUGH-THERAPY-DESIGNATED DRUG FOR B7-H4-TARGETED ANTIBODY-DRUG CONJUGATE HS-20089Further company coverage: 3692.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R838I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2532022707","title":"Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated Drug for B7-H4-Targeted Antibody-Drug Conjugate Hs-20089","url":"https://stock-news.laohu8.com/highlight/detail?id=2532022707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532022707?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:20","pubTimestamp":1746094829,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R838I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2532022843","title":"Innovent Biologics - Qtrly Achieved Total Product Revenue Exceeding RMB2.4 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2532022843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532022843?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:01","pubTimestamp":1746093699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R838E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01801","LU2488822045.USD","LU2328871848.SGD","BK1161","LU1969619763.USD","BK1589","BK1583"],"gpt_icon":0},{"id":"2532040337","title":"Central China New Life Makes Senior Management Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2532040337","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532040337?lang=en_us&edition=fundamental","pubTime":"2025-05-01 14:39","pubTimestamp":1746081592,"startTime":"0","endTime":"0","summary":"Dai Jiling has resigned as Central China New Life's  CEO and an executive director effective Wednesday, a same-day Hong Kong bourse filing said.The move comes in order for Dai to devote time to handling other work related to the CCRE Group.The firm, on the same day, named Wang Jun as its new CEO. Wang has previously held the role of CEO from October 2019 to February 2022.The property management and value-added services provider has also appointed Guo Liyuan as an executive Director and the CFO, effective the same day.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1229","BK1542","09983","BK1583","BK1258","MKR.USD.HKCC"],"gpt_icon":0},{"id":"2531054739","title":"BRIEF-Central China New Life Says Dai Jiling Resigns As Executive Director And CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2531054739","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531054739?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:13","pubTimestamp":1746026034,"startTime":"0","endTime":"0","summary":"BRIEF-Central China New Life Says Dai Jiling Resigns As Executive Director And CEOApril 30  - Central China New Life Ltd 9983.HK:DAI JILING RESIGNED AS AN EXECUTIVE DIRECTOR AND CEOWANG JUN APPOINTED AS CEOGUO LIYUAN APPOINTED BY BOARD AS EXECUTIVE DIRECTOR AND CFOFurther company coverage: 9983.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R82DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1542","BK1229","BK1258","09983","BK1583"],"gpt_icon":0},{"id":"2531056871","title":"Central China New Life - Guo Liyuan Appointed by Board as Executive Director and CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2531056871","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531056871?lang=en_us&edition=fundamental","pubTime":"2025-04-30 22:12","pubTimestamp":1746022338,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R82DC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1258","BK1583","BK1229","09983","BK1542"],"gpt_icon":0},{"id":"2531744067","title":"BRIEF-Sunac Services Exits Zhangtai Services Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2531744067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531744067?lang=en_us&edition=fundamental","pubTime":"2025-04-30 09:40","pubTimestamp":1745977213,"startTime":"0","endTime":"0","summary":"BRIEF-Sunac Services Exits Zhangtai Services GroupApril 30 (Reuters) - Sunac Services Holdings Ltd 1516.HK:EXITS ZHANGTAI SERVICES GROUPSELLS 80% EQUITY FOR RMB826.62 MILLIONFurther company coverage: 1516.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R72FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1542","01516","BK1585","BK1258","BK1229","BK1583"],"gpt_icon":0},{"id":"2531743631","title":"BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation","url":"https://stock-news.laohu8.com/highlight/detail?id=2531743631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531743631?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:19","pubTimestamp":1745972342,"startTime":"0","endTime":"0","summary":"BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect OperationApril 30  - Beigene 688235.SS:SAYS PHARMACYCLICS LITIGATION IS NOT HAVING ADVERSE EFFECT ON DEVELOPMENT, SALES OF BRUKINSA IN U.S.SAYS PHARMACYCLICS LITIGATION IS NOT EXPECTED TO HAVE companyADVERSE EFFECT ON CO'S PRODUCTION, OPERATIONSource textFurther company coverage: 688235.SS  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R801B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","BK1583","LU0588546209.SGD","LU2328871848.SGD","688235","BK1500","BK1588","06160","LU1969619763.USD","BK0239","BK1161"],"gpt_icon":0},{"id":"2531487697","title":"Beigene  Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531487697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531487697?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:19","pubTimestamp":1745972341,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R801B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688235","LU0588546209.SGD","LU0307460666.USD","LU1969619763.USD","BK0239","BK1583","06160","BK1500","BK1161","LU2328871848.SGD","BK1588"],"gpt_icon":0},{"id":"2531107657","title":"Innovent Announces First Patient Dosed in Phase 1 Study of Ibi3020, Global First-in-Class Dual Payload Ceacam5 ADC,  in Patients With Advanced Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2531107657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531107657?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:00","pubTimestamp":1745971203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA8TXXPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","BK1161","BK1589","BK1583","LU2328871848.SGD","LU2488822045.USD","01801"],"gpt_icon":0},{"id":"2531482227","title":"Sunac Services Holdings Ltd. Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2531482227","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531482227?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:33","pubTimestamp":1745969589,"startTime":"0","endTime":"0","summary":"Sunac Services Holdings Ltd. has released its annual report for the year 2024. The company, listed on the Main Board of The Stock Exchange of Hong Kong Limited, reported a revenue of approximately RMB6,969.5 million for the year ended 31 December 2024. This represents a slight decrease of around RMB40.0 million, or 0.6%, compared to the RMB7,009.5 million recorded in the previous year. The decline in revenue is attributed primarily to a reduction in income from value-added services to non-property owners. Revenue from third parties increased by 5.6% to RMB6,801,695, while revenue from related parties fell by 70.6% to RMB167,806. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nNDL98V73Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1240","BK1521","01516","BK1258","BK1229","BK1542","BK1555","01918","BK1585","BK1583"],"gpt_icon":0},{"id":"2531717635","title":"Sunac Services Holdings Ltd - Exits Zhangtai Services Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2531717635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531717635?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:30","pubTimestamp":1745969435,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R72FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01516","BK1258","BK1585","BK1229","BK1583","BK1542"],"gpt_icon":0},{"id":"2531731795","title":"China Suntien Green Energy's Q1 Profit Swells 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531731795","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531731795?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:06","pubTimestamp":1745932007,"startTime":"0","endTime":"0","summary":"China Suntien Green Energy  recorded a 15% rise in attributable profit in the first quarter to 954.5 million yuan from 832.1 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.Earnings per share stood at 0.23 yuan in the three months, up from 0.20 yuan in the year-ago period.The natural gas and wind power generation company's operating revenue fell 13% to 6.91 billion yuan from 7.91 billion yuan previously.The lower operating revenue was mainly due to a year-over-year decline in the natural gas sales volume.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600956","BK0252","BK1583","00956","BK1166","BK1558","BK1594","BK1503"],"gpt_icon":0},{"id":"2531735946","title":"Microport Scientific - Qtrly Net Profit for Shanghai Microport Endovascular Medtech RMB129.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2531735946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531735946?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:37","pubTimestamp":1745930257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R720F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688016","BK1583","BK1100","BK0251","00853","BK1589","BK1585"],"gpt_icon":0},{"id":"2531084382","title":"JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec  Decreases to 6.28% on April 24 From 7.33% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2531084382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531084382?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:17","pubTimestamp":1745918275,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70V5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02359","603259","LU0456842615.SGD","LU2242644610.SGD","LU2495084118.USD","LU0052750758.USD","LU1997245177.USD","BK1576","LU1997244956.HKD","LU0708995583.HKD","BK1141","BK1583","LU1046422090.SGD","LU2045819591.USD","LU0320764599.SGD","LU2125910500.SGD","BK0216","LU1997245094.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2531223627","title":"Tong Ren Tang Technologies' Q1 Profit Reaches 227 Million Yuajn","url":"https://stock-news.laohu8.com/highlight/detail?id=2531223627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531223627?lang=en_us&edition=fundamental","pubTime":"2025-04-29 13:57","pubTimestamp":1745906268,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies' (HKG:1666) attributable net profit reached 227.2 million yuan in the first quarter, according to preliminary data filed Monday with the Hong Kong bourse.Revenue at the traditional Chinese medicine manufacturer reached 2.04 billion yuan, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01666","TGRNF","BK1606","BK1191","BK1583","BK1515","BK4007"],"gpt_icon":0},{"id":"2531217077","title":"BUZZ-China's WuXi AppTec jumps as Q1 profit soars","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217077?lang=en_us&edition=fundamental","pubTime":"2025-04-29 10:55","pubTimestamp":1745895332,"startTime":"0","endTime":"0","summary":"BUZZ-China's WuXi AppTec jumps as Q1 profit soars** Hong Kong shares of WuXi AppTec Co 2359.HK jump 7.4% to HK$62.5, their highest since April 3, and on course for the second session of gains** Stock set for the biggest one-day rise since March 18; second-biggest gainer on Hang Seng Index .HSI, which climbs 0.6%** Shanghai-listed stock 6032593.SS rises 5.1% to 61.07 yuan, highest since April 3, and on the 9th consecutive session of gain ** The Chinese new drug research and development and manufacturing services group said its Q1 net profit up 89.1% y/y** Citi, with \"buy\" rating, says 1Q25 results beat and the result was strong** Hang Seng Commerce & Industry Index .HSNC gains 0.9%, healthcare index .HSCIH rises 1.9%** YTD, Hong Kong stock up 10.4%, Shanghai shares up 10.2% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL1N3R7027:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","BK4559","LU2495084118.USD","BK4585","BK4534","LU0128525689.USD","LU2045819591.USD","LU1791807156.HKD","LU2236285917.USD","BK1583","LU2462157665.USD","LU2125910500.SGD","BK1576","LU1046422090.SGD","LU0072461881.USD","LU0310800965.SGD","LU1997245094.SGD","LU2125154778.USD","LU0052756011.USD","LU1997244956.HKD","LU2242644610.SGD","BK4504","LU2417539215.USD","BK0216","603259","LU1668664300.SGD","LU0456842615.SGD","02359","BK4566","LU0098860793.USD","LU0320764599.SGD","LU1997245177.USD","IE00BSNM7G36.USD","LU1267930227.SGD","LU0170899867.USD","BK1141","LU1162221912.USD","LU2488822045.USD","LU0052750758.USD","LU2125154935.USD","LU2456880835.USD","LU0648001328.SGD","LU0162691827.USD","LU0980610538.SGD","LU0106831901.USD","BK4207","LU0130102774.USD","BK4588","LU0708995583.HKD","LU0130517989.USD"],"gpt_icon":0},{"id":"2531293702","title":"Innovent Biologics Inc. Releases Environmental, Social and Governance Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2531293702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531293702?lang=en_us&edition=fundamental","pubTime":"2025-04-29 06:12","pubTimestamp":1745878376,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. has published its Environmental, Social and Governance Report. The report highlights a reduction in annual plastic use by approximately 40 tons, contributing to sustainable development. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief on April 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL8VT1cG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1583","LU2328871848.SGD","01801","BK1161","BK1147","01911","LU1969619763.USD","BK1589"],"gpt_icon":0},{"id":"2531297293","title":"China Resources Mixc Lifestyle Services Ltd. Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2531297293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531297293?lang=en_us&edition=fundamental","pubTime":"2025-04-29 06:11","pubTimestamp":1745878298,"startTime":"0","endTime":"0","summary":"China Resources Mixc Lifestyle Services Ltd. has released its Annual Report for 2024, providing insights into its business operations and financial performance. The company, a leading property management and commercial operational services provider in China, highlighted its inclusion in the Hong Kong Hang Seng Index constituents as of November 18, 2022, and its selection into the \"Double Hundred Enterprises\" list by the State-owned Assets Supervision and Administration Commission in 2023. The report reflects the company's strategic focus on creating a world-class enterprise and becoming a highly influential asset-light management company in China. China Resources Mixc Lifestyle Services Ltd. continues to emphasize its integrated \"2+1\" business model, combining commercial management, property management, and a large membership system. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL8kvtwx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0738912210.USD","LU0048597586.USD","LU1366334651.USD","01209","LU0791590937.USD","BK1589","LU1880383366.USD","LU0067412154.USD","IE0008368742.USD","LU0048580855.USD","LU0417516902.SGD","LU1152091168.USD","BK1542","LU1023057109.AUD","LU0501845795.SGD","LU0605514214.HKD","LU0791591158.USD","LU1152091754.HKD","01109","LU0173614495.USD","LU0456827905.SGD","LU1008478684.HKD","LU2088748376.SGD","BK1240","LU0051755006.USD","LU0359202008.SGD","LU2088747998.USD","LU0594300179.USD","LU1993786604.SGD","LU1807302812.USD","LU2088748293.HKD","LU0414403682.SGD","LU2088748020.USD","BK1583","BK1555","LU0348825331.USD","BK1258","LU0359201612.USD","BK1521","BK1229","LU1960683339.HKD","SG9999009997.SGD","SG9999014674.SGD","SG9999010052.SGD","LU0456846285.SGD","LU0251144936.SGD","SG9999010078.USD","LU0287142896.SGD","BK1570","LU0650527681.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}